tirzepatide discontinuation weight regain study Exercise program helps prevent some gain after stopping anti-obesity drugs Effects of Tirzepatide on Body

Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg and gradually titrated upward to maintenance doses ranging from 5 mg to 15 mg weekly, depending on individual tolerance and response

Nausea is the most common complaint, affecting a significant percentage of patients during the first month and after each dose escalation

The MDL, created to coordinate discovery and pretrial proceedings, originally included a bellwether program to evaluate representative claims, with the first trial slated for June 2026

The product ships internationally, sometimes disguised as cosmetics or skincare products to avoid customs scrutiny

SURMOUNT-4 Investigators

Experiments in primary islets reveal -arrestin1 limits the insulin response to GLP-1, but not GIP or tirzepatide, suggesting that the biased agonism of tirzepatide enhances insulin secretion